Skip to main content
. 2022 Nov 19;37(1):35–46. doi: 10.1038/s41375-022-01732-9

Fig. 3. Death in patients with cardiovascular adverse-drug reactions with ibrutinib reported to VigiBase from its creation in November 1967 to February 2018.

Fig. 3

Adapted from [13]. CNS central nervous system, SVA supraventricular arrhythmia, VA ventricular arrhythmia.